Back to Search
JILL MCMULLEN, MD
MD
Family Medicine Physician
NPI: 1740285998IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
47949(WI)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1998
Research & Publications (20)
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.
PMID 19679877·Am J Pathol·2009
7-preclinical
Nectin-2: an intercalated disc protein that maintains cardiac function in a setting of pressure overload.
PMID 19667253·Hypertension·2009
7-preclinical
Role of phosphoinositide 3-kinases in regulating cardiac function.
PMID 19273196·Front Biosci (Landmark Ed)·2009
6-review
The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.
PMID 19175355·Clin Sci (Lond)·2009
6-review
Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction.
PMID 19129376·Am J Physiol Regul Integr Comp Physiol·2009
7-preclinical
Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.
PMID 19122165·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Promoting physiological hypertrophy in the failing heart.
PMID 18307737·Clin Exp Pharmacol Physiol·2008
6-review
Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.
PMID 18290876·Clin Exp Pharmacol Physiol·2008
6-review
Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
PMID 18267957·Cardiovasc Res·2008
7-preclinical
Acceptance versus distraction: brief instructions, metaphors and exercises in increasing tolerance for self-delivered electric shocks.
PMID 17949683·Behav Res Ther·2008
2-rct
Resistin, an adipocytokine, offers protection against acute myocardial infarction.
PMID 17904155·J Mol Cell Cardiol·2007
7-preclinical
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
PMID 17660828·Nat Med·2007
7-preclinical
Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension.
PMID 17414655·J Hypertens·2007
8-other
PI3K(p110alpha) inhibitors as anti-cancer agents: minding the heart.
PMID 17404510·Cell Cycle·2007
7-preclinical
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
PMID 17324134·Clin Exp Pharmacol Physiol·2007
6-review
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
PMID 17202264·Proc Natl Acad Sci U S A·2007
7-preclinical
Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy.
PMID 17019808·Novartis Found Symp·2006
6-review
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
PMID 16983087·Proc Natl Acad Sci U S A·2006
7-preclinical
Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
PMID 16298682·Free Radic Biol Med·2005
4-observational
Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.
PMID 16227599·Mol Cell Biol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1330 N SUPERIOR AVE
TOMAH, WI 54660 - Phone
- (608) 372-4111
Quick Facts
- NPI
- 1740285998
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile